Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study

Journal of Hypertension

Volumn 20, Issue 3, 2002, Pages 405-412

  Wachtell, Kristian ^a   Olsen, Michael H ^a   Dahlöf, Björn ^a   Devereux, Richard B ^a   Kjeldsen, Sverre E ^a   Nieminen, Markku S ^a   Okin, Peter M ^a   Papademetriou, Vasilios ^a   Mogensen, Carl E ^a   Borch Johnsen, Knut ^a   Ibsen, Hans ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Electrocardiography; Left ventricular hypertrophy; Microalbuminuria

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ETHNIC DIFFERENCE; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; PRIORITY JOURNAL; RACE DIFFERENCE; SMOKING;

EID: 0036492044     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200203000-00015     Document Type: Article

References (44)

1. Increased urinary albumin-excretion rate in benign essential hypertension
2. Micro-albuminuria as a predictor of cardiovascular damage in essential hypertension
3. Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension
4. Microalbuminuria as predictor of vascular disease in non-diabetic subjects
5. Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease
6. Microalbuminuria as predictor of increased mortality in elderly people
7. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
8. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension
9. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults
10. Electrocardiographic detection of left ventricular hypertrophy: Development and prospective validation of improved criteria
11. Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: Validation with autopsy findings
12. Left ventricular hypertrophy: Relationship of anatomic, echocardiographic and electrocardiographic findings
13. Sensitivity of electrocardiographic criteria for left ventricular hypertrophy according to type of cardiac disease
14. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy
15. Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product
16. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products
17. Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension
18. Urinary albumin excretion. An independent predictor of ischemic heart disease
19. Factors related to the presence of microalbuminuria in essential hypertension
20. Left ventricular hypertrophy and function in high, normal, and low-renin forms of essential hypertension
21. A long-term study of plasma catecholamine levels and plasma renin activity in borderline hypertension
22. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease
23. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study
24. Characteristics of 9194 patients with left ventericular hypertrophy: The LIFE study
25. Gender differences and the electrocardiogram in left ventricular hypertrophy
26. Improved electrocardiographic detection of echocardiographic left ventricular hypertrophy: Results of a correlated data base approach
27. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and link leads
28. Diagnostic value of microalbuminuria in pre-eclampsia
29. Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes?
30. Detecting microalbuminuria by urinary albumin/creatinine concentration ratio
31. Microalbuminuria: An early marker of renal involvement in diabetes
32. Microalbuminuria: An important diagnostic tool
33. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: The Losartan intervention for endpoint reduction (LIFE) in hypertension study
34. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: The LIFE study
35. Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study)
36. Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study)
37. Prevalence and clinical correlates of microalbuminuria in essential hypertension: The MAGIC study
38. Renal and systemic transvascular albumin leakage in severe atherosclerosis
39. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects
40. Prevalence and clinical correlates of microalbuminuria in stage I hypertension. Results from the Hypertension and Ambulatory Recording Venetia Study (HARVEST Study)
41. Relation of concentric left ventricular hypertrophy and extracardiac target organ damage to supranormal left ventricular performance in established essential hypertension
42. Endothelial dysfunction in resistance arteries is related to high blood pressure and circulating low density lipoproteins in previously treated hypertension
43. Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study
44. Comparison of overnight, morning and 24-hour urine collections in the assessment of diabetic microalbuminuria